Cost-effectiveness analysis of the bivalent compared with the quadrivalent human papillomavirus vaccines in Taiwan. [electronic resource]
Producer: 20121015Description: 622-31 p. digitalISSN:- 1524-4733
- Child
- Cost-Benefit Analysis
- Drug Costs
- Female
- Human papillomavirus 11 -- immunology
- Human papillomavirus 16 -- immunology
- Human papillomavirus 18 -- immunology
- Human papillomavirus 6 -- immunology
- Humans
- Markov Chains
- Mass Vaccination -- economics
- Models, Economic
- Papillomavirus Infections -- economics
- Papillomavirus Vaccines -- administration & dosage
- Quality-Adjusted Life Years
- Taiwan -- epidemiology
- Uterine Cervical Neoplasms -- economics
- Uterine Cervical Dysplasia -- economics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.